Mycobacterium Tuberculosis: Molecular Infection Biology, Pathogenesis, Diagnostics and New Interventions

Mycobacterium Tuberculosis: Molecular Infection Biology, Pathogenesis, Diagnostics and New Interventions

Hasnain, Seyed Ehtesham; Grover, Sonam; Ehtesham, Nasreen Z.

Springer Verlag, Singapore

12/2020

514

Mole

Inglês

9789813294158

15 a 20 dias

961

Descrição não disponível.
Chapter 1. Molecular and Infection biology of M. tuberculosis.- Chapter 1.1. The new knowledge on the PE_PGRS proteins, eventually extending the summary on PE/PPE.- Chapter 1.2. The PE and PPE family proteins of mycobacteria: What they are upto?- Chapter 1.3. Co-operonic and non-co-operonic PE-PPE genes and their function.- Chapter 1.4. Methyltransferases of Mycobacterium tuberculosis.- Chapter 1.5. Heat shock proteins as drug target.- Chapter 1.6. Poly-?-L-glutamine: a multifunctional molecule in mycobacterial cell wall contributes to biofilm formation, virulence and cell wall integrity.- Chapter 1.7. Celluar stress responses and immunological regulations during M. Tuberculosis infection.- Chapter 2. Pathology and Epidemiology of Tuberculosis-. Chapter 2.1. Nontuberculous mycobacteria as emerging pathogens: challenges in diagnostics, treatment and pathogenicity research.- Chapter 2.2. Mesenchymal stem cells: A hidden arsenal for M.tuberculosis persistence, resuscitation and reactivation.- Chapter 2.3. Charting the patho-epidemiological interconnectivity between tuberculosis and non-communicable disease.- Chapter 2.4. MDR-TB in Australia and cross-border spread of strains.- Chapter 3. Vaccines, Diagnostics and Clinics.- Chapter 3.1. TB Vaccine: Present and Future Perspective.- Chapter 3.2. Role of nanotechnology in improving M. tuberculosis diagnosis sensitive, faster, cheaper and deployable.- Chapter 3.3. Best Practices in M. tuberculosis Research.
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
Mycobacterium tuberculosis;Virulence and pathogenesis;Mesenchymal stem cells;Host pathogen interactions;Nontuberculous mycobacteria;infectious diseases;vaccines